Ehud Geller

Dr. Ehud Geller has been active in the health care/biopharma and life science industries for over 30 years. The former president and CEO of Interpharm Laboratories, Ltd., he presided over the growth of this company from the seed stage to $18 million in revenues. Prior to that, Dr. Geller was the president of the Pharmaceutical Division of Teva and Executive VP of the Teva Group, Israel´s largest pharmaceutical company. At Teva, he led the merger of the pharmaceutical business involved in the acquisition of Ikapharm Ltd., and the strategy of Teva´s entry into the U.S. market. Earlier, Dr. Geller conducted pharmaceutical research at Wyeth Laboratories in the U.S.

Dr. Geller has a B.Sc. degree in chemical engineering, an MBA from Columbia University, and a Ph.D. degree in pharma/chemical engineering from Drexel Institute. He serves as founder and director of biotech and device health care companies.